EMEND
NDC 0006-0462, aprepitant, capsule, from Merck Sharp & Dohme LLC.
- Product NDC
- 0006-0462
- Status
- Listed
- Labeler
- Merck Sharp & Dohme LLC
- Dosage form
- CAPSULE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA021549
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/0006-0462 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- APREPITANT125 mg/1
Pharmacologic classes
Cytochrome P450 2C9 Inducers [MoA]; Cytochrome P450 3A4 Inducers [MoA]; Cytochrome P450 3A4 Inhibitors [MoA]; Neurokinin 1 Antagonists [MoA]; Substance P/Neurokinin-1 Receptor Antagonist [EPC]
| Package NDC | NDC-11 | Package |
|---|
Linked data
RxNorm, label and prices
RxNorm concepts
RxNorm links no concept to this product's packages.
Related lookups
FDA label sections
GET /v1/drugs/labels/696f9e80-9cae-403b-de9e-078343ce4713
Use it
Look up 0006-0462 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/0006-0462 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 0006-0462. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.